@MonashCID

The Monash University Centre for Inflammatory Diseases spans basic experimental biology, clinical research and clinical practice in inflammatory diseases.

 Melbourne, Australia
monash.edu/medicine/scs/research/cid
Joined January 2020
  • Tweets294
  • Following170
  • Followers234
37Media
MonashCID retweeted
Fabien VINCENT@FabOzyOct 12
What if we could restore immune tolerance instead of suppressing the entire #ImmuneSystem? We developed Ro60-specific Tregs for #SjogrensDisease, bringing antigen-specific cell therapy one step closer to reality 🔗 @iScience_CP: cell.com/iscience/fulltext/S… @SCSMonash @MonashCID
1
1
18
MonashCID retweeted
Fabien VINCENT@FabOzySep 11
📢 More than dryness symptoms. Our new @OUPAcademic population-based study shows increased mortality in #SjogrensDisease, highlighting the need for better treatments and improved prevention of systemic complications academic.oup.com/rheumatolog… @UniofAdelaide @MonashCID @SCSMonash

Mortality and causes of death in patients with Sjögren disease in Western Australia: a population...

AbstractObjectives. Sjögren disease (SjD) is a systemic autoimmune disorder with emerging evidence showing increased mortality rates compared with the gene

academic.oup.com
2
3
47
MonashCID retweeted
Fabien VINCENT@FabOzyAug 24
Delighted to see our review on #Sjogrens, led by PhD candidate Dr Cristina Pelkas, published in @MedTodayJournal! 🎉 Beyond #sicca symptoms: Diagnosis and management of #SjogrensDisease medicinetoday.com.au/mt/2026… #Rheumatology @MonashCID @SCSMonash
1
1
32
New research from Dr Cameron Bastow et al. in ICMx A murine gram‑negative sepsis model with standard care that meets Sepsis‑3 criteria and mirrors clinical pathology. A valuable tool for translational sepsis research. doi.org/10.1186/s40635-026-0… @SCSMonash @MonashCID @cwonglab
33
MonashCID retweeted
ImmuMon@ImmuMonMar 2
ImmuMon is back for 2026! 🗓️ 11th September 📍 Alfred Research Alliance, Innovation & Education Hub We are currently seeking sponsors, please contact us at [email protected] to get involved.
1
3
121
Glad to share our recent paper exploring self management strategies in #lupus patients - we need tailored education that promotes patient activation. @SCSMonash sciencedirect.com:5037/scien…
2
3
413
Congratulations to Professors Graeme Polglase and Connie Wong, awarded 2025 @heartfoundation grants for innovative research in newborn resuscitation and stroke-related inflammation. Their work continues to advance cardiovascular health across the lifespan. 🔗 Read more: bit.ly/3LD1CjM #HeartFoundation #Research #CardiovascularHealth #Monash
1
7
444
Last chance everyone! Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026 Case reports and case series are welcome And remember the new Young Invstigator Award Session. See you in 2026!
ANZ Vasculitis Society, '26 Vasculitis Wkshop host@anzvasc18 Sep 2025
We’re giving you more time to share your work at the upcoming International Vasculitis Workshop. The new deadline to submit your abstract is 29 September 2025! Don't miss your opportunity, submit today at vasculitis-melbourne2026.com…
1
2
224
Proud to share @ZhiLim8's latest review on promising new treatments for #Sjogrens! 🧬 How engineered regulatory T cell therapies could help rebalance the immune system and bring relief to patients? @OoiLabs @alberta_hoi @MonashCID @SCSMonash @MonashHealth sciencedirect.com/science/ar…
3
4
283
New @SCSMonash research led by @cwonglab and Dr Joshua Bourne shows microglia, not invading immune cells, drive damaging inflammation in the first hours after stroke. Targeting these brain-resident cells could protect function and improve recovery. Read more 👉 monash.edu/medicine/news/lat… #StrokeResearch @MonashUni @Monash_FMNHS
2
4
227
Replying to @SCSMonash
@SCSMonash Monash University/Monash Health is making important advances against Sjögren’s disease in Australia, through establishment of Monash Sjögren Registry. See more about the disease insightplus.mja.com.au/2025/…

Sjögren’s disease in Australia: why we need to pay attention

Most of us have heard of Sjögren’s disease (or Sjögren’s syndrome), an autoimmune condition that targets moisture-producing glands. We associate it with…

insightplus.mja.com.au
1
1
67
Fabulous collaboration between @SCSMonash @MonashCID @Hudson_Research and A/Prof Grant Logan from @CMRI_AUS harnessing gene therapy to deliver therapeutic doses of DNaseI to clear extracellular DNA release from NETs in experimental ANCA Vasculitis.
JCI insight
@JCI_insight19 Aug 2025
Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis? @Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis. See full report: insight.jci.org/articles/vie…
5
10
668
Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis? @Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis. See full report: insight.jci.org/articles/vie…
4
2
14
1,973
MonashCID retweeted
ImmuMon@ImmuMon30 Jul 2025
2 WEEKS TO GO! Abstract submissions for #ImmuMon2025 close in just TWO WEEKS! Don’t miss your chance to share your latest immunology research with researchers across Monash University. Abstract Deadline: 15th August Submit now: immumon.com/registration-abs…
2
4
7
267
Congrats to Prof Richard Kitching on the 2025 APSN Award for Excellence in Basic Science 👏 A leader in autoimmune kidney research at @MonashUni and @MonashHealth, and co-founder of ANZVASC. Read more: bit.ly/4nONbYF #Nephrology #Vasculitis #KidneyResearch #ClinicalSciences #MonashHealth #MonashUniversity
1
3
176
Time is critical in AAV: dampening kidney inflammation prevents damage Why not target effector T cells - leave other T cells alone? Our paper in @NDTSocial defines IL-7Ra as a target doi.org/10.1093/ndt/gfae276 Anti-IL-7Ra Abs are in Phase 2 trials - alopecia @Q32Bio ?an AAV therapy

Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis

ABSTRACTBackground and hypothesis. Increased T-cell interkeukin (IL)-7Rα signalling is associated with a poorer prognosis in anti-neutrophil cytoplasmic an

academic.oup.com
1
14
1
38
7,155
Proud to share this work led by @cpelkas highlighting exciting new treatment developments for #Sjogrens—alongside a concerning lack of diversity in clinical trials. Greater inclusivity is essential @MonashCID @SCSMonash @UniofAdelaide @TQEHofficial sciencedirect.com/science/ar…
4
1
8
725
Big congratulations to our newly promoted academic leaders at @SCSMonash! 👏 Professors @alberta_hoi, @DrKPalmer and @cwonglab 👏 Associate Professors @DrAyseZ, @PFaridi, @SimonAJoosten1, Nicole Kellow, Mary-Ann Davey and Calum Roberts. We’re proud to celebrate an all-woman cohort of Level E promotions this year, a milestone for equity in academic leadership. #ClinicalSciences #MonashHealth #AcademicExcellence #WomenInSTEM #STEMLeadership #PromotionCelebration
1
8
305
Delighted to share this collaborative work published in Best Prac Res and Clinical #rheumatology highlighting the latest therapeutic advances and assessing clinical trial inclusivity in #Sjogrens @MonashCID @SCSMonash @cpelkas @UniofAdelaide @TQEHofficial sciencedirect.com/science/ar…
1
1
49
IL-7Ra signalling in AAV links to relapse/resistance Our recent paper 🔹defined activated & exhausted T cells in experimental AAV kidneys 🔹neutralised IL-7Ra - a non-depleting mAb - to limit ANCA-associated GN Similar mAbs are in Phase 2 clinical trials academic.oup.com/ndt/article…

Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis

ABSTRACTBackground and hypothesis. Increased T-cell interkeukin (IL)-7Rα signalling is associated with a poorer prognosis in anti-neutrophil cytoplasmic an

academic.oup.com
2
7
20
1,118
Load more